Age-related cerebral white matter disease (leukoaraiosis): a review
Tóm tắt
With the availability of improved brain imaging techniques, the high prevalence and clinical importance of cerebral small vessel disease have been increasingly recognised in recent years. As age is one of the most important risk factors for this condition, its prevalence is set to rise further as populations age. This may lead to an increase in the clinical consequences of white matter disease, namely cognitive decline, decreased mobility and increased stroke risk. Given the impact this will have on individuals and on healthcare systems, knowledge of the risk factors for small vessel disease, its prevention and its treatment is becoming more important. Although a lot of data are now available on the epidemiology, risk factors, clinical consequences and prognosis of leukoaraiosis, some of this information is conflicting. In this review, we summarise the current literature on cerebral small vessel disease, with an emphasis on its clinical aspects.
Từ khóa
Tài liệu tham khảo
Debette, 2010, The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis, BMJ, 341, c3666, 10.1136/bmj.c3666
Binswanger, 1894, Die Abgrenzung der allgemeinen progressiven Paralyse, Berl Klin Wochenschr, 31, 1180
Alzheimer, 1902, Die Seelenstörung auf arteriosklerotischer Grundlage, Allg Z Psychiat, 59, 695
Grinberg, 2010, Vascular pathology in the aged human brain, Acta Neuropathol, 119, 277, 10.1007/s00401-010-0652-7
Knottnerus, 2009, Endothelial dysfunction in lacunar stroke: a systematic review, Cerebrovasc Dis, 27, 519, 10.1159/000212672
Stevenson, 2010, A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls, Stroke, 41, 434, 10.1161/STROKEAHA.109.569855
Topakian, 2010, Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis, J Neurol Neurosurg Psychiatry, 81, 192, 10.1136/jnnp.2009.172072
Jickling, 2009, Circulating endothelial progenitor cells and age-related white matter changes, Stroke, 40, 3191, 10.1161/STROKEAHA.109.554527
Baune, 2009, Association between cytokines and cerebral MRI changes in the aging brain, J Geriatr Psychiatry Neurol, 22, 23, 10.1177/0891988708328216
Wardlaw, 2009, Lacunar stroke is associated with diffuse blood-brain barrier dysfunction, Ann Neurol, 65, 194, 10.1002/ana.21549
Black, 2009, Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment, Stroke, 40, S48, 10.1161/STROKEAHA.108.537704
Fazekas, 1993, Pathologic correlates of incidental MRI white matter signal hyperintensities, Neurology, 43, 1683, 10.1212/WNL.43.9.1683
Fernando, 2006, White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury, Stroke, 37, 1391, 10.1161/01.STR.0000221308.94473.14
Pantoni, 1995, The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review, Stroke, 26, 1293, 10.1161/01.STR.26.7.1293
Khan, 2007, Risk factor profile of cerebral small vessel disease and its subtypes, J Neurol Neurosurg Psychiatry, 78, 702, 10.1136/jnnp.2006.103549
Lammie, 2005, Pathology & Genetics. Cerebrovascular Diseases, 85
Greenberg, 2009, Cerebral microbleeds: a guide to detection and interpretation, Lancet Neurol, 8, 165, 10.1016/S1474-4422(09)70013-4
Jeong, 2002, Hypertensive pontine microhemorrhage, Stroke, 33, 925, 10.1161/01.STR.0000013563.73522.CB
Longstreth, 1996, Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study, Stroke, 27, 1274, 10.1161/01.STR.27.8.1274
Breteler, 1994, Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study, Stroke, 25, 1109, 10.1161/01.STR.25.6.1109
Appelman, 2010, White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study, Cerebrovasc Dis, 29, 28, 10.1159/000255971
Wahlund, 2001, A new rating scale for age-related white matter changes applicable to MRI and CT, Stroke, 32, 1318, 10.1161/01.STR.32.6.1318
van Den Boom, 2002, Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, Radiology, 224, 791, 10.1148/radiol.2243011123
O'Sullivan, 2001, MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL, Neurology, 56, 628, 10.1212/WNL.56.5.628
van Swieten, 1990, Grading white matter lesions on CT and MRI: a simple scale, J Neurol Neurosurg Psychiatry, 53, 1080, 10.1136/jnnp.53.12.1080
Scheltens, 1998, White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes, Eur Neurol, 39, 80, 10.1159/000007921
Hopkins, 2006, Prevalence of white matter hyperintensities in a young healthy population, J Neuroimaging, 16, 243, 10.1111/j.1552-6569.2006.00047.x
de Leeuw, 2001, Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study, J Neurol Neurosurg Psychiatry, 70, 9, 10.1136/jnnp.70.1.9
Longstreth, 1998, Brain abnormalities in the elderly: frequency and predictors in the United States (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group, J Neural Transm Suppl, 53, 9, 10.1007/978-3-7091-6467-9_2
Dufouil, 2001, Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort, Neurology, 56, 921, 10.1212/WNL.56.7.921
Breteler, 1994, Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study, Neurology, 44, 1246, 10.1212/WNL.44.7.1246
Gao, 2008, Silent cerebral microbleeds on susceptibility-weighted imaging of patients with ischemic stroke and leukoaraiosis, Neurol Res, 30, 272, 10.1179/016164107X251556
Park, 2007, Significant association between leukoaraiosis and metabolic syndrome in healthy subjects, Neurology, 69, 974, 10.1212/01.wnl.0000266562.54684.bf
Unal, 2004, Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000, Circulation, 109, 1101, 10.1161/01.CIR.0000118498.35499.B2
Lovelock, 2007, Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study, Lancet Neurol, 6, 487, 10.1016/S1474-4422(07)70107-2
Padovani, 1997, Correlates of leukoaraiosis and ventricular enlargement on magnetic resonance imaging: a study in normal elderly and cerebrovascular patients, Eur J Neurol, 4, 15, 10.1111/j.1468-1331.1997.tb00295.x
Streifler, 1995, Lack of relationship between leukoaraiosis and carotid artery disease. The North American Symptomatic Carotid Endarterectomy Trial, Arch Neurol, 52, 21, 10.1001/archneur.1995.00540250025008
Srikanth, 2009, Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study, Stroke, 40, 175, 10.1161/STROKEAHA.108.524355
van Dijk, 2008, Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study, Stroke, 39, 2712, 10.1161/STROKEAHA.107.513176
Simoni, 2010, Validity of CT versus MR brain imaging in studies of risk factors for Leukoaraiosis: a systematic review, Cerebrovasc Dis, 29, 300
Gottesman, 2010, Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study, Stroke, 41, 3, 10.1161/STROKEAHA.109.566992
Meadows, 2009, Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry, Am Heart J, 158, 1038, 10.1016/j.ahj.2009.09.014
Birns, 2009, Cerebrovascular reactivity and dynamic autoregulation in ischaemic subcortical white matter disease, J Neurol Neurosurg Psychiatry, 80, 1093, 10.1136/jnnp.2009.174607
Bokura, 2008, Metabolic syndrome is associated with silent ischemic brain lesions, Stroke, 39, 1607, 10.1161/STROKEAHA.107.508630
Anan, 2009, Visceral fat accumulation is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients, Eur J Clin Invest, 39, 368, 10.1111/j.1365-2362.2009.02103.x
Bogousslavsky, 1987, Leukoencephalopathy in patients with ischemic stroke, Stroke, 18, 896, 10.1161/01.STR.18.5.896
Koçer, 2005, Heart failure with low cardiac output and risk of development of lesions in the cerebral white matter, Eur Gen Med, 2, 56
Ohmine, 2008, Association between arterial stiffness and cerebral white matter lesions in community-dwelling elderly subjects, Hypertens Res, 31, 75, 10.1291/hypres.31.75
Manolio, 1999, Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group, Arterioscler Thromb Vasc Biol, 19, 356, 10.1161/01.ATV.19.2.356
Ikram, 2008, Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease, Stroke, 39, 1421, 10.1161/STROKEAHA.107.501106
Lindgren, 1994, Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study, Stroke, 25, 929, 10.1161/01.STR.25.5.929
de Lau, 2009, Plasma vitamin B12 status and cerebral white-matter lesions, J Neurol Neurosurg Psychiatry, 80, 149, 10.1136/jnnp.2008.149286
Pieters, 2009, Periventricular white matter lucencies relate to low vitamin B12 levels in patients with small vessel stroke, Stroke, 40, 1623, 10.1161/STROKEAHA.108.523431
Wright, 2005, Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study, Stroke, 36, 1207, 10.1161/01.STR.0000165923.02318.22
Hassan, 2004, Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction, Brain, 127, 212, 10.1093/brain/awh023
Carmelli, 1998, Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins, Stroke, 29, 1177, 10.1161/01.STR.29.6.1177
Turner, 2004, Heritability of leukoaraiosis in hypertensive sibships, Hypertension, 43, 483, 10.1161/01.HYP.0000112303.26158.92
Brickman, 2011, White matter hyperintensities and cognition: testing the reserve hypothesis, Neurobiol Aging, 32, 1588, 10.1016/j.neurobiolaging.2009.10.013
Jokinen, 2009, Longitudinal cognitive decline in subcortical ischemic vascular disease—the LADIS Study, Cerebrovasc Dis, 27, 384, 10.1159/000207442
Podgorska, 2002, Leukoaraiosis and stroke outcome, J Stroke Cerebrovasc Dis, 11, 336, 10.1053/jscd.2002.130123
Teodorczuk, 2010, Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study, Psychol Med, 40, 603, 10.1017/S0033291709990857
Baezner, 2008, Association of gait and balance disorders with age-related white matter changes: the LADIS study, Neurology, 70, 935, 10.1212/01.wnl.0000305959.46197.e6
Enzinger, 2007, Progression of cerebral white matter lesions—clinical and radiological considerations, J Neurol Sci, 257, 5, 10.1016/j.jns.2007.01.018
Berger, 2005, The association between white matter lesions, stroke and activities of daily living—the MEMO study on the KORA platform Augsburg, Gesundheitswesen, S172, 10.1055/s-2005-858233
Fu, 2005, Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke, J Neurol Neurosurg Psychiatry, 76, 793, 10.1136/jnnp.2003.032771
Schmidt, 1999, MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study, Neurology, 53, 132, 10.1212/WNL.53.1.132
Taylor, 2003, Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors, Am J Roentgenol, 181, 571, 10.2214/ajr.181.2.1810571
van Dijk, 2005, C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study, Circulation, 112, 900, 10.1161/CIRCULATIONAHA.104.506337
Longstreth, 2005, Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study, Stroke, 36, 56, 10.1161/01.STR.0000149625.99732.69
Gouw, 2008, Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability Study, Stroke, 39, 1414, 10.1161/STROKEAHA.107.498535
Almkvist, 1992, White-matter hyperintensity and neuropsychological functions in dementia and healthy aging, Arch Neurol, 49, 626, 10.1001/archneur.1992.00530300062011
Bronge, 2003, Prognostic significance of white matter changes in a memory clinic population, Psychiatry Res, 122, 199, 10.1016/S0925-4927(03)00005-2
Bracco, 1993, Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: a longitudinal study, J Neurol Sci, 120, 131, 10.1016/0022-510X(93)90263-X
Schmidt, 2002, The natural course of MRI white matter hyperintensities, J Neurol Sci, 203–204, 253, 10.1016/S0022-510X(02)00300-3
Whitman, 2001, A prospective study of cerebral white matter abnormalities in older people with gait dysfunction, Neurology, 57, 990, 10.1212/WNL.57.6.990
Ovbiagele, 2006, Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications, Cerebrovasc Dis, 22, 83, 10.1159/000093235
Dufouil, 2005, Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy, Circulation, 13, 1644, 10.1161/CIRCULATIONAHA.104.501163
ten Dam, 2005, Effect of pravastatin on cerebral infarcts and white matter lesions, Neurology, 64, 1807, 10.1212/01.WNL.0000161844.00797.73
Ruland, 2003, Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?, Curr Atheroscler Rep, 5, 38, 10.1007/s11883-003-0067-1
Mok, 2009, Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study, J Neurol, 256, 750, 10.1007/s00415-009-5008-7
Aktas, 2003, Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies, Stroke, 34, 764, 10.1161/01.STR.0000056527.34434.59
Kato, 2002, Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis, Stroke, 33, 1536, 10.1161/01.STR.0000018012.65108.86
Lee, 2005, Effects of microbleeds on hemorrhage development in leukoaraiosis patients, Hypertens Res, 28, 895, 10.1291/hypres.28.895
Palumbo, 2007, Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke, Neurology, 68, 1020, 10.1212/01.wnl.0000257817.29883.48
Neumann-Haefelin, 2006, Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke, Stroke, 37, 2463, 10.1161/01.STR.0000239321.53203.ea
Gorter, 1999, Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors, Neurology, 53, 1319, 10.1212/WNL.53.6.1319